Hirszfeld Institute of Immunology and Experimental Therapy at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Hirszfeld Institute of Immunology and Experimental Therapy brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on redirecting T cells against blood cancers. It covers finding tumour-reactive receptors against PRAME and CLL-1 through antigen-specific priming and single-cell sequencing, then comparing receptor-engineered and CAR T cells head to head.

OrganizationESGCT 2026 Attendance
Poster
Wed Oct 28
1:30pm–3:30pm
Identification of tumor-reactive TCRs targeting PRAME and CLL-1 using antigen-specific in vitro priming and single-cell sequencing
Immunotherapy and CAR T cells
Poster
Wed Oct 28
1:30pm–3:30pm
Phenotypic and Functional Comparison of CAR-T and TCR-T Cells in Hematologic Malignancies
Immunotherapy and CAR T cells

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hirszfeld Institute of Immunology and Experimental Therapy

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction